Exclusive-J&J near disclosing support for talc settlement, sources say Investing.com Exclusive-J&J near disclosing support for talc settlement, sources say. Johnson & Johnson (JNJ) 1 month
Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for Growth Insider Monkey 1 day
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? Investor's Business Daily 3 days
Is Johnson & Johnson (JNJ) the Best Blue Chip Stock To Invest In According to Short Sellers? Insider Monkey 5 days
Johnson & Johnson (JNJ) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks
Is Johnson & Johnson (JNJ) The Best Dividend Paying Stock To Buy According to Quant Hedge Fund AQR? Insider Monkey 3 weeks
Johnson & Johnson (JNJ): A Cheap Pharmaceutical Stock to Buy According to Short Sellers Insider Monkey 3 weeks
The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback CNBC 3 weeks
Is Johnson & Johnson (JNJ) The Best Among The S&P 500 Dividend Aristocrats According to Hedge Funds? Insider Monkey 4 weeks
J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reports Investing.com 1 month
J&J has enough support from claimants for $6.5 billion talc settlement – Bloomberg Investing.com 1 month